Evidence map›Paper›PMID 24492608›Full record

ArticleThe Journal of biological chemistry2014

Antifibrotic effects of noscapine through activation of prostaglandin E2 receptors and protein kinase A.

Jacob Kach, Nathan Sandbo, Jennifer La, Darcy Denner, Eleanor B Reed, Olga Akimova, Svetlana Koltsova, Sergei N Orlov, Nickolai O Dulin

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
5.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Cysteine-rich domain of type III collagen N-propeptide inhibits fibroblast activation by attenuating TGFβ signaling.Matrix biology : journal of the International Society for Matrix Biology · 2022
    Article
  7. Article
  8. Expression of serum response factor in the lung mesenchyme is essential for development of pulmonary fibrosis.American journal of physiology. Lung cellular and molecular physiology · 2021
    Article
  9. Article
  10. Article
  11. Prostaglandin EAmerican journal of physiology. Lung cellular and molecular physiology · 2019
    Article
  12. Sustained Smad2 Phosphorylation Is Required for Myofibroblast Transformation in Response to TGF-β.American journal of respiratory cell and molecular biology · 2019
    Article
  13. Inhibition of Phosphoglycerate Dehydrogenase Attenuates Bleomycin-induced Pulmonary Fibrosis.American journal of respiratory cell and molecular biology · 2018
    Article
  14. Article
  15. Myofibroblast repair mechanisms post-inflammatory response: a fibrotic perspective.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2017
    Review
  16. Article
  17. SIRT3 blocks myofibroblast differentiation and pulmonary fibrosis by preventing mitochondrial DNA damage.American journal of physiology. Lung cellular and molecular physiology · 2017
    Article
  18. Article
  19. Regulation of myofibroblast differentiation by cardiac glycosides.American journal of physiology. Lung cellular and molecular physiology · 2016
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Jacob KachFrom the Department of Medicine, University of Chicago, Chicago, Illinois 60637.
Nathan Sandbo
Jennifer La
Darcy Denner
Eleanor B Reed
Olga Akimova
Svetlana Koltsova
Sergei N Orlov
Nickolai O Dulin
University of Chicago · USLomonosov Moscow State University · RUUniversity of Wisconsin–Madison · US

Funding

RESEARCH TRAINING IN RESPIRATORY BIOLOGYT32HL007605 · NHLBI · UNIVERSITY OF CHICAGO · PI Yun Fang, Gokhan M. Mutlu · 1985 to 2026
$18.1M
CARDIOVASCULAR PATHOPHYSIOLOGY &BIOCHEMISTRY TRAININGT32HL007237 · NHLBI · UNIVERSITY OF CHICAGO · PI GETZ, GODFREY SHALOM · 1985 to 2011
$5.0M
Novel functions of RGS3R01GM085058 · NIGMS · UNIVERSITY OF CHICAGO · PI DULIN, NICKOLAI O · 2009 to 2012
$1.2M
Signaling Pathways Regulating Serum Response Factor in Pulmonary FibrosisK08HL093367 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI SANDBO, NATHAN K · 2009 to 2013
$621k
NHLBI NIH HHS K08 HL093367NHLBI NIH HHS K08 HL093367-01A1NHLBI NIH HHS T32 HL007237NHLBI NIH HHS T32HL007237NHLBI NIH HHS T32 HL007605NIGMS NIH HHS R01 GM085058NIGMS NIH HHS R01 GM85058
6 · The paper itself

Abstract

Myofibroblast differentiation is a key process in the pathogenesis of fibrotic disease. We have shown previously that differentiation of myofibroblasts is regulated by microtubule polymerization state. In this work, we examined the potential antifibrotic effects of the antitussive drug, noscapine, recently found to bind microtubules and affect microtubule dynamics. Noscapine inhibited TGF-β-induced differentiation of cultured human lung fibroblasts (HLFs). Therapeutic noscapine treatment resulted in a significant attenuation of pulmonary fibrosis in the bleomycin model of the disease. Noscapine did not affect gross microtubule content in HLFs, but inhibited TGF-β-induced stress fiber formation and activation of serum response factor without affecting Smad signaling. Furthermore, noscapine stimulated a rapid and profound activation of protein kinase A (PKA), which mediated the antifibrotic effect of noscapine in HLFs, as assessed with the PKA inhibitor, PKI. In contrast, noscapine did not activate PKA in human bronchial or alveolar epithelial cells. Finally, activation of PKA and the antifibrotic effect of noscapine in HLFs were blocked by the EP2 prostaglandin E2 receptor antagonist, PF-04418948, but not by the antagonists of EP4, prostaglandin D2, or prostacyclin receptors. Together, we demonstrate for the first time the antifibrotic effect of noscapine in vitro and in vivo, and we describe a novel mechanism of noscapine action through EP2 prostaglandin E2 receptor-mediated activation of PKA in pulmonary fibroblasts.

Indexed as

AnimalsAntineoplastic AgentsAntitussive AgentsBleomycinCell Line, TumorCyclic AMP-Dependent Protein KinasesDNAFibroblastsFibrosisGene Expression RegulationHumansHydroxyprolineLuciferasesLungMiceMice, Inbred C57BLAntineoplastic AgentsAntitussive AgentsBleomycinCyclic AMP-Dependent Protein KinasesDNAHydroxyprolineLuciferasesNoscapineReceptors, Prostaglandin EFibrosisMicrotubulesMyofibroblastNoscapineProstaglandinsProtein Kinase A (PKA)SRFStress Fibers

Identifiers

PMID24492608
PMCPMC3953264
OpenAlexW2106539849

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.